PRMT5 and systemic sclerosis: With respect to the relation between anti-PRMT5 antibodies and skin or lung score trajectories of the patients with SSc, we investigated if the occurrence and dynamic changes of these antibodies may fluctuate in parallel with the skin and lung changes during the disease course.